Avalo Therapeutics (AVTX) Amortization - Intangibles (2017 - 2022)
Avalo Therapeutics (AVTX) posted Amortization - Intangibles of $38000.0 for Q1 2022, down 85.77% on a QoQ basis from $267000.0 in Q4 2021, and down 91.04% year-over-year from $424000.0 in Q1 2021.
Avalo Therapeutics (AVTX) Amortization - Intangibles (2017 - 2022) Analysis & Trends
Avalo Therapeutics' Amortization - Intangibles history runs 6 years deep, the most recent figure standing at $38000.0 for Q1 2022.
- Quarterly Amortization - Intangibles fell 91.04% year-over-year to $38000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $38000.0 (down 97.54% YoY) and the FY2022 annual result came in at $38000.0, down 97.55% from the prior year.
- Amortization - Intangibles was $38000.0 for Q1 2022 at Avalo Therapeutics, down from $267000.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $1.2 million in Q2 2018 and bottomed at -$1.5 million in Q4 2018.
- A 5-year average of $382032.1 and a median of $404000.0 in 2020 frame the typical range for Amortization - Intangibles.
- Annual changes were most pronounced in 2018 — Amortization - Intangibles sank 468.58% — and 2019, when it soared 122.51%.
- Avalo Therapeutics' Amortization - Intangibles stood at -$1.5 million in 2018, then surged by 122.51% to $334753.0 in 2019, then surged by 50.26% to $503000.0 in 2020, then tumbled by 46.92% to $267000.0 in 2021, then plunged by 85.77% to $38000.0 in 2022.
- Business Quant data shows AVTX's Amortization - Intangibles at $38000.0 in Q1 2022, $267000.0 in Q4 2021, and $428000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 428,000.00 |
| Jun 30, 2021 | 428,000.00 |
| Mar 31, 2021 | 424,000.00 |
| Dec 31, 2020 | 503,000.00 |
| Sep 30, 2020 | 404,000.00 |
| Jun 30, 2020 | 404,000.00 |
| Mar 31, 2020 | 431,000.00 |
| Dec 31, 2019 | 334,753.00 |
| Sep 30, 2019 | 334,748.00 |
| Jun 30, 2019 | 334,747.00 |
| Mar 31, 2019 | 334,748.00 |
| Dec 31, 2018 | -1.49 Mn |
| Sep 30, 2018 | 1.07 Mn |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 1.02 Mn |
| Dec 31, 2017 | 403,520.00 |